首页> 外文OA文献 >Prior switching to a second-line nonsteroidal antiandrogen does not impact the therapeutic efficacy of abiraterone acetate in patients with metastatic castration-resistant prostate cancer: a real-world retrospective study

【2h】

Prior switching to a second-line nonsteroidal antiandrogen does not impact the therapeutic efficacy of abiraterone acetate in patients with metastatic castration-resistant prostate cancer: a real-world retrospective study

机译：前后切换到第二线非甾体抗衰老原，不会影响醋酸甲酸乙酸阿替萘抗性前列腺癌患者的治疗效果：真实的回顾性研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Ming Shi; Hao Zeng; Jin-Ge Zhao; Jian-Dong Liu; Peng-Fei Shen; Xin Tang; Guang-Xi Sun; Xing-Ming Zhang; Jun-Ru Chen; Kun-Peng Shu;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Prior switching to a second-line nonsteroidal antiandrogen does not impact the therapeutic efficacy of abiraterone acetate in patients with metastatic castration-resistant prostate cancer: a real-world retrospective study [J] . Jin-Ge Zhao, Jian-Dong Liu, Peng-Fei Shen, Asian journal of andrology . 2018,第6期

机译：现实世界的回顾性研究表明，在切换至二线非甾体类抗雄激素药物之前，不会影响醋酸阿比特龙对转移性去势抵抗性前列腺癌患者的治疗效果。
2. Prior switching to a second-line nonsteroidal antiandrogen does not impact the therapeutic efficacy of abiraterone acetate in patients with metastatic castration-resistant prostate cancer:a real-world retrospective study [J] . Jin-Ge Zhao, Hao Zeng, Jian-Dong Liu, 亚洲男性学杂志（英文版） . 2018,第006期

机译：改用二线非甾体类抗雄激素药不会影响醋酸阿比特龙对转移性去势抵抗性前列腺癌患者的治疗效果：一项现实世界的回顾性研究
3. A Retrospective, Canadian Multi-Center Study Examining the Impact of Prior Response to Abiraterone Acetate on Efficacy of Docetaxel in Metastatic Castration-Resistant Prostate Cancer [J] . Azad Arun A., Leibowitz-Amit Raya, Eigl Bernhard J., The Prostate . 2014,第15期

机译：加拿大的一项多中心回顾性研究，研究了醋酸阿比特龙的先前反应对多西他赛在去势抵抗性前列腺癌中的作用的影响。
4. 3D spheroid culture systems for metastatic prostate cancer dormancy studies and anti-cancer therapeutics development. [D] . Hsiao, Amy Yu-Ching. 2011

机译：用于转移性前列腺癌休眠研究和抗癌疗法开发的3D球体培养系统。
5. Prior switching to a second-line nonsteroidal antiandrogen does not impact the therapeutic efficacy of abiraterone acetate in patients with metastatic castration-resistant prostate cancer: a real-world retrospective study [O] . Jin-Ge Zhao, Jian-Dong Liu, Peng-Fei Shen, 2018

机译：现实世界的回顾性研究表明在切换至二线非甾体类抗雄激素药物之前不会影响醋酸阿比特龙对转移性去势抵抗性前列腺癌患者的治疗效果。
6. Real-World Safety and Efficacy Outcomes with Abiraterone Acetate Plus Prednisone or Prednisolone as the First- or Second-Line Treatment for Metastatic Castration-Resistant Prostate Cancer: Data from the Prostate Cancer Registry [O] . Anders Bjartell, Nicolaas Lumen, Pablo Maroto, 2021

机译：与AbiraTerone醋酸盐加上泼尼松或泼尼松龙作为转移性阉割前列腺癌的第一或第二线治疗的现实世界的安全和疗效结果：来自前列腺癌登记处的数据

Prior switching to a second-line nonsteroidal antiandrogen does not impact the therapeutic efficacy of abiraterone acetate in patients with metastatic castration-resistant prostate cancer: a real-world retrospective study

著录项

相似文献

相关主题

期刊订阅